147 related articles for article (PubMed ID: 33832871)
1. Management of patients with inflammatory bowel disease and outcomes during the first wave of the Covid-19 pandemic.
Viola A; Giambò F; Chiappetta MF; Costantino G; Pallio S; Fries W
Dig Liver Dis; 2021 Jun; 53(6):689-690. PubMed ID: 33832871
[No Abstract] [Full Text] [Related]
2. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.
Bekic D; Belosic Halle Z
Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Bowel Disease and the SARS-CoV-2 Pandemic: More Speed, Less Haste.
Gower-Rousseau C; Fumery M; Pariente B;
Gastroenterology; 2021 Jan; 160(1):473-474. PubMed ID: 32389663
[No Abstract] [Full Text] [Related]
4. Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.
Aysha AA; Rentsch C; Prentice R; Johnson D; Bryant RV; Ward MG; Costello SP; Lewindon P; Ghaly S; Connor SJ; Begun J; Christensen B
Intern Med J; 2020 Jul; 50(7):798-804. PubMed ID: 32656985
[TBL] [Abstract][Full Text] [Related]
5. The COVID-19 pandemic shows us in which way the care of patients with inflammatory bowel disease should move.
Hernández Ramírez V; López Serrano P
Rev Esp Enferm Dig; 2021 Feb; 113(2):153-154. PubMed ID: 33467860
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Decisions in Inflammatory Bowel Disease in the SARS-Cov-2 Pandemic.
Brain O; Satsangi J
Gastroenterology; 2021 Apr; 160(5):1883-1884. PubMed ID: 32553759
[No Abstract] [Full Text] [Related]
7. Management of inflammatory bowel diseases in the wake of COVID-19 pandemic.
Pasha SB; Fatima H; Ghouri YA
J Gastroenterol Hepatol; 2020 Aug; 35(8):1449-1450. PubMed ID: 32246874
[No Abstract] [Full Text] [Related]
8. Establishing Safe Out-of-Hospital Infusion Centers May Improve the Quality of Care in Patients With IBD During the COVID-19 Pandemic.
Behzad C; Taheri H; Kashifard M
Inflamm Bowel Dis; 2020 Oct; 26(11):e140. PubMed ID: 32901275
[No Abstract] [Full Text] [Related]
9. Inflammatory Bowel Disease Management in a Major Referral Center During COVID-19 Pandemic.
Garrido I; Lopes S; Macedo G
Inflamm Bowel Dis; 2020 Sep; 26(10):e114-e115. PubMed ID: 32737966
[No Abstract] [Full Text] [Related]
10. Low frequency of COVID-19 in inflammatory bowel diseases.
Marafini I; Salvatori S; Sena G; Calabrese E; Biancone L; Monteleone G
Dig Liver Dis; 2020 Nov; 52(11):1234-1235. PubMed ID: 32601036
[No Abstract] [Full Text] [Related]
11. Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic.
Grossberg LB; Pellish RS; Cheifetz AS; Feuerstein JD
Inflamm Bowel Dis; 2021 May; 27(6):940-946. PubMed ID: 32619010
[No Abstract] [Full Text] [Related]
12. Psychological Challenges for Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.
Borghi L; Poli S; Furfaro F; Allocca M; Vegni EAM
Psychosom Med; 2021 May; 83(4):397-398. PubMed ID: 33234778
[No Abstract] [Full Text] [Related]
13. IBD in the COVID-19 era: the value of international collaboration.
Brenner EJ; Ungaro RC; Colombel JF; Kappelman MD
Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):887-888. PubMed ID: 32941833
[No Abstract] [Full Text] [Related]
14. Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic".
Khorshid M; AbdAllah M
Inflamm Bowel Dis; 2021 Mar; 27(4):e39. PubMed ID: 33512472
[No Abstract] [Full Text] [Related]
15. COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy.
Viganò C; Massironi S; Pirola L; Cristoferi L; Fichera M; Bravo M; Mauri M; Redaelli AE; Dinelli ME; Invernizzi P
Inflamm Bowel Dis; 2020 Oct; 26(11):e138-e139. PubMed ID: 32949238
[No Abstract] [Full Text] [Related]
16. Commenting on the Letter (Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic").
Eltabbakh M; Abd Alaty W; Sakr MA; Sherief AF
Inflamm Bowel Dis; 2021 Apr; 27(5):e66. PubMed ID: 33512507
[No Abstract] [Full Text] [Related]
17. Inflammatory Bowel Disease and COVID-19-"Preventive" Sick Certificates as a Frequent Coping Strategy in the Face of the Pandemic.
Schlabitz F; Teich N; Michl P; Walldorf J
Inflamm Bowel Dis; 2020 Aug; 26(9):e105-e106. PubMed ID: 32530027
[No Abstract] [Full Text] [Related]
18. COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment?
Caron B; Arondel Y; Reimund JM
Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2637-2638. PubMed ID: 32522559
[No Abstract] [Full Text] [Related]
19. Balancing Risks and Benefits in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic.
Kotze PG; Peyrin-Biroulet L; Danese S
Gastroenterology; 2021 Jan; 160(1):472-473. PubMed ID: 32422207
[No Abstract] [Full Text] [Related]
20. SARS-CoV-2 infection in patients with inflammatory bowel disease in the second-third wave and its comparison with data of first wave of pandemic.
Algaba A; Guerra I; Castro S; Bermejo F
Gastroenterol Hepatol; 2022; 45(7):572-573. PubMed ID: 34774924
[No Abstract] [Full Text] [Related]
[Next] [New Search]
